Research & Development



  雲瑯正在給甦稚按摩小腿,聞言皺起了眉頭。   懷孕的女人脾氣變化多端,不管甦稚說什麼,雲瑯都用笑臉兜著,只要她的心情能好起來,其余的無所謂。欧美色情在线-777米奇色狠狠俺去啦-俺也来俺也去俺也射成人网   曹襄先看看老虎腦袋上傷痕安慰性的拍拍老虎的胖臉,對雲瑯道︰“可惜了,外邊全是拉人的。”caoprn超碰最新地址   雲瑯狐疑的瞅了曹襄一眼,騎馬走過去一看,很快又回來了,曹襄說的沒錯,全是匈奴人,不過,從他們熟練地耕地動作來看,又不像是匈奴人。   “這是今春的第一茬枇杷是吧?來自蜀中?”超碰视频在线

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo